Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
110.467 3.06 (2.70%)

NAV as on 21 May, 2018

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Dec 2017) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 21 May, 2018)

Period Returns (%) Rank #
1 mth -8.9 8
3 mth -10.1 8
6 mth -13.5 8
1 year -13.5 8
2 year -9.6 8
3 year -7.6 6
5 year 11.3 4

# Moneycontrol Rank within 8 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2017 5.7 -9.3 -3.7 9.2 1.5
2016 -11.5 1.9 5.0 -11.2 -14.2
2015 17.3 -3.0 6.4 -0.8 27.0
2014 4.2 14.8 23.7 6.3 56.3
2013 -3.0 9.0 6.4 8.4 25.7

View where it stands within its peers

* Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -8.9 -10.1 -13.5 -13.5 -9.6 -7.6 11.3
Category avg -4.6 -7.1 -4.0 -5.4 -5.0 -2.8 8.4
Difference of Fund returns and Category returns -4.3 -3.0 -9.5 -8.1 -4.6 -4.8 2.9
Best of category -6.1 -2.8 -2.2 5.4 1.7 0.7 14.3
Worst of category -8.9 -10.1 -13.5 -13.5 -9.6 -7.6 9.1
Benchmark returns # -9.4 -8.8 -9.5 -13.2 -8.5 -9.2 --
Difference of Fund returns and Benchmark returns 0.5 -1.3 -4.0 -0.3 -1.1 1.6 11.3
# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jul 31, 1999
Benchmark S&P BSE HEALTHCARE
Asset Size (Rs cr) 828.41 (Mar-31-2018)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Tanmaya Desai
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 0.50%
Load Comments Exit load charge will be 0.50 if redemmed before 15 days 15th july 2016.

Contact Details

Regd. Office 191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No. 91 22 22180221/ 27
Fax No. 91 22 22189663
Email partnerforlife@sbimf.com
Website http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,695.82 -3.0 -2.6 4.4 -0.2 13.4
Reliance Pharma Fund - Direct (G) Not Ranked
258.39 -2.8 -2.2 5.4 0.7 14.3
SBI Pharma Fund (G) Not Ranked
828.41 -10.1 -13.5 -13.5 -7.6 11.3
SBI Pharma Fund - Direct (G) Not Ranked
218.21 -9.8 -13.0 -12.4 -6.4 12.5
UTI Healthcare Fund (G) Not Ranked
362.92 -9.6 -9.3 -8.3 -6.6 9.1
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Apr 30, 18)

Equity Sector Value
(Rs cr)
Asset %
Cipla Pharmaceuticals 99.61 9.84
Sun Pharma Pharmaceuticals 84.54 8.35
Divis Labs Pharmaceuticals 83.83 8.28
Strides Shasun Pharmaceuticals 70.13 6.92
Torrent Pharma Pharmaceuticals 62.41 6.16
Alkem Lab Pharmaceuticals 59.29 5.85
Cadila Health Pharmaceuticals 54.43 5.37
Aurobindo Pharm Pharmaceuticals 51.36 5.07
Gufic Bio Pharmaceuticals 46.74 4.62
Aster DM Health Conglomerates 35.65 3.52

Full Portfolio

Sector Allocation (Apr 30, 18)

Sector %

1-Year

HighLow

Pharmaceuticals 84.39 88.75 88.75
Services 6.21 7.68 7.68
Conglomerates 3.52 0.00 0.00

View All Sectors

Asset Allocation (%)(Apr 30, 18)

Equity 94.12
Others 0.65
Debt 0.00
Mutual Funds N.A
Money Market 5.73
Cash / Call -0.50

View All

Concentration

Holdings (%)
Top 5 39.55
Top 10 63.98
Sector (%)
Top 3 94.12

News & Videos

News

Messages & Community

Sections
Follow us on
Available On